TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
When case Id is present, search is done only for this
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All Case Laws
of of All Case Laws
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Court approves dispensation for Equity Shareholders & Secured Creditors in Amalgamation Scheme under Companies Act</h1> <h3>In Re : Zyg Pharma Private Limited</h3> The Court granted dispensation from convening meetings of Equity Shareholders and Secured Creditors for the Scheme of Arrangement for Amalgamation between ... Scheme of Arrangement in the nature of Amalgamation - Held that:- All these consent letters are annexed with the application as Exhibit' D'. Similarly, all the Secured Creditors of the applicant Company have approved the Scheme in form of written consent letters. All these consent letters are annexed with the application as Exhibit' E'. There are no Unsecured Creditors of the applicant Company as on date. The certificates confirming the status of the Shareholders and Creditors as well as the receipt of the consent letters from all the Shareholders and Secured Creditors are annexed respectively as Exhibit' F', 'F1', and 'F2'. In view of the same, dispensation is sought from convening the meetings of the Equity Shareholders and Secured Creditors of the applicant Company. Considering the above facts and circumstances and the submissions advanced at the Bar, the same is hereby granted. Issues:Scheme of Arrangement for Amalgamation under Sections 391-394 of Companies Act, 1956 - Dispensation of meetings of Equity Shareholders and Secured Creditors.Analysis:The judgment pertains to a Scheme of Arrangement for the Amalgamation of Zyg Pharma Private Limited with Torrent Pharmaceuticals Limited, the Transferee Company, under Sections 391 to 394 of the Companies Act, 1956. The application for dispensation of meetings of Equity Shareholders and Secured Creditors of the applicant Company was filed by Zyg Pharma Private Limited, the Transferee Company. The applicant Transferor Company is a wholly owned subsidiary of the Transferee Company, and all Equity Shareholders of the applicant Company, including the Holding Company and its nominees, have approved the Scheme through written consent letters, which are annexed with the application as Exhibit 'D'. Similarly, all Secured Creditors of the applicant Company have also approved the Scheme through written consent letters, annexed as Exhibit 'E'. Notably, there are no Unsecured Creditors of the applicant Company. Certificates confirming the status of Shareholders and Creditors, along with the receipt of consent letters, are annexed as Exhibit 'F', 'F1', and 'F2'. Consequently, dispensation from convening meetings of Equity Shareholders and Secured Creditors of the applicant Company is sought and granted based on the submissions and circumstances presented.The Court, after considering the facts and submissions put forth, has granted the dispensation from convening the meetings of Equity Shareholders and Secured Creditors of the applicant Company. The application for the Scheme of Arrangement for Amalgamation has been disposed of accordingly. The judgment reflects a thorough evaluation of the compliance with legal requirements and the approval process for the proposed Amalgamation, ensuring that all necessary consents and approvals have been obtained from the relevant stakeholders. The decision underscores the importance of adherence to procedural formalities and the significance of obtaining consent from shareholders and creditors in corporate restructuring processes governed by the Companies Act, 1956.
TaxTMI 
TaxTMI 
